123 related articles for article (PubMed ID: 22624806)
1. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.
Wang X; Wang X; Xie G; Zhou M; Yu H; Lin Y; Du G; Luo G; Jia W; Liu P
J Proteome Res; 2012 Jul; 11(7):3838-47. PubMed ID: 22624806
[TBL] [Abstract][Full Text] [Related]
2. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
[TBL] [Abstract][Full Text] [Related]
3. A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.
Lian JS; Liu W; Hao SR; Guo YZ; Huang HJ; Chen DY; Xie Q; Pan XP; Xu W; Yuan WX; Li LJ; Huang JR
Chin Med J (Engl); 2011 May; 124(9):1367-73. PubMed ID: 21740750
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
[TBL] [Abstract][Full Text] [Related]
5. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
6. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
[TBL] [Abstract][Full Text] [Related]
7. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
Kozłowska J; Łoch T; Jabłońska J; Cianciara J
Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
[TBL] [Abstract][Full Text] [Related]
11. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
12. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
13. [Functional MRI in chronic liver disease of hepatitis B patients].
Wang K; Wang PJ; Zhao ZH; Wang Z; Xu SS; Liu WJ; Rui YP; Xue XY
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):590-6. PubMed ID: 16938171
[TBL] [Abstract][Full Text] [Related]
14. Chronic liver disease and cirrhosis among patients with hepatitis B virus infection in northern Portugal with reference to the viral genotypes.
Mota A; Areias J; Cardoso MF
J Med Virol; 2011 Jan; 83(1):71-7. PubMed ID: 21108341
[TBL] [Abstract][Full Text] [Related]
15. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
17. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus.
Zhang L; Jia X; Peng X; Ou Q; Zhang Z; Qiu C; Yao Y; Shen F; Yang H; Ma F; Wang J; Yuan Z
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):688-98. PubMed ID: 20810534
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
Qiu Y; Cai G; Su M; Chen T; Zheng X; Xu Y; Ni Y; Zhao A; Xu LX; Cai S; Jia W
J Proteome Res; 2009 Oct; 8(10):4844-50. PubMed ID: 19678709
[TBL] [Abstract][Full Text] [Related]
20. Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry.
Lian J; Li X; Wang Y; Yang J; Liu W; Ma J; Chen D; Li L; Huang J
Biomed Pharmacother; 2016 Dec; 84():994-1000. PubMed ID: 27768929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
